These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11115793)

  • 1. Micronutrients and host resistance to viral infection.
    Beck MA; Matthews CC
    Proc Nutr Soc; 2000 Nov; 59(4):581-5. PubMed ID: 11115793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice.
    Beck MA
    Biomed Environ Sci; 1997 Sep; 10(2-3):307-15. PubMed ID: 9315324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidants and viral infections: host immune response and viral pathogenicity.
    Beck MA
    J Am Coll Nutr; 2001 Oct; 20(5 Suppl):384S-388S; discussion 396S-397S. PubMed ID: 11603647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign human enterovirus becomes virulent in selenium-deficient mice.
    Beck MA; Kolbeck PC; Rohr LH; Shi Q; Morris VC; Levander OA
    J Med Virol; 1994 Jun; 43(2):166-70. PubMed ID: 8083665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates.
    Beck MA; Shi Q; Morris VC; Levander OA
    Nat Med; 1995 May; 1(5):433-6. PubMed ID: 7585090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice.
    Beck MA; Kolbeck PC; Shi Q; Rohr LH; Morris VC; Levander OA
    J Infect Dis; 1994 Aug; 170(2):351-7. PubMed ID: 8035022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper deficiency increases the virulence of amyocarditic and myocarditic strains of coxsackievirus B3 in mice.
    Smith AD; Botero S; Levander OA
    J Nutr; 2008 May; 138(5):849-55. PubMed ID: 18424590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency.
    Beck MA
    J Nutr; 1997 May; 127(5 Suppl):966S-970S. PubMed ID: 9164275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
    Horwitz MS; La Cava A; Fine C; Rodriguez E; Ilic A; Sarvetnick N
    Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interacting nutritional and infectious etiologies of Keshan disease. Insights from coxsackie virus B-induced myocarditis in mice deficient in selenium or vitamin E.
    Levander OA; Beck MA
    Biol Trace Elem Res; 1997 Jan; 56(1):5-21. PubMed ID: 9152508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression analysis during recovery process indicates the mechanism for innate immune injury and repair from Coxsackievirus B3-induced myocarditis.
    Yao HL; Song J; Sun P; Song QQ; Sheng LJ; Chi MM; Han J
    Virus Res; 2016 Feb; 213():314-321. PubMed ID: 26779987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxsackievirus B3-resistant mice become susceptible in Se/vitamin E deficiency.
    Beck MA; Williams-Toone D; Levander OA
    Free Radic Biol Med; 2003 May; 34(10):1263-70. PubMed ID: 12726914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune interleukin-1 receptor-associated kinase 4 exacerbates viral myocarditis by reducing CCR5(+) CD11b(+) monocyte migration and impairing interferon production.
    Valaperti A; Nishii M; Liu Y; Naito K; Chan M; Zhang L; Skurk C; Schultheiss HP; Wells GA; Eriksson U; Liu PP
    Circulation; 2013 Oct; 128(14):1542-54. PubMed ID: 24030499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral damage or 'molecular mimicry'-placing the blame in myocarditis.
    Rose NR
    Nat Med; 2000 Jun; 6(6):631-2. PubMed ID: 10835674
    [No Abstract]   [Full Text] [Related]  

  • 15. Selenium and viral virulence.
    Levander OA; Beck MA
    Br Med Bull; 1999; 55(3):528-33. PubMed ID: 10746343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis?
    Qian Q; Xiong S; Xu W
    Future Microbiol; 2012 Oct; 7(10):1207-16. PubMed ID: 23030425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
    Henke A; Jarasch N; Martin U; Wegert J; Wildner A; Zell R; Wutzler P
    Int J Med Microbiol; 2008 Jan; 298(1-2):127-34. PubMed ID: 17897883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart.
    Fairweather D; Frisancho-Kiss S; Yusung SA; Barrett MA; Davis SE; Steele RA; Gatewood SJ; Rose NR
    J Immunol; 2005 Jan; 174(1):261-9. PubMed ID: 15611248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.